帕迪4依赖性NETosis使饮食诱导的肠道过性成为可能,将dysbiosis转化为全身炎症和消化不良
Mattia Albiero1,2, Ludovica Migliozzi2,3, Carlotta Boscaro2,3
1Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
Diabetes
|February 13, 2025
概括
氨基氨酸减小酶4 (PADI4) 驱动中性粒细胞外细胞陷 (NET) 的形成,将饮食诱导的微生物群变化与代谢功能障碍联系起来. 抑制PADI4可以防止肠道屏障破坏和代谢疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
- 微生物组研究的研究.
背景情况:
- 中性粒细胞外细胞陷 (NETs),通过基氨酸减小酶4 (PADI4) 释放,可以传播炎症.
- 与肥胖相关的失糖症与脂肪组织中的NETosis有关.
- 高脂肪饮食 (HFD) 诱导了代谢功能障碍,炎症和NETosis.
研究的目的:
- 研究PADI4在调解饮食修饰微生物群对宿主新陈代谢影响中的作用.
- 确定PADI4依赖性NETosis是否有助于代谢性内毒性和肠道屏障功能障碍.
- 探索PADI4抑制作为饮食诱导的代谢疾病的治疗策略.
主要方法:
- 利用Padi4淘汰赛 (Padi4KO) 的小鼠和药物 PADI4 抑制.
- 向小鼠进行高脂肪饮食 (HFD),以诱导代谢功能障碍和炎症.
- 评估肠道屏障完整性,新陈代谢参数,肝脂肪症和全身炎症.
- 研究了从HFD养的小鼠移植到Padi4KO小鼠的微生物群的影响.
主要成果:
- 在小鼠中,HFD诱导了代谢不良,炎症和NETosis.
- 在保护免受HFD诱导的肝脏和脂肪炎症和改善新陈代谢的造血细胞中的 Padi4 缺失.
- 废除NETosis保留了肠道屏障功能,并减少了代谢性内毒性.
- Padi4KO小鼠得到了保护,免受HFD微生物群诱导的超透性和代谢障碍.
- 药理上的PADI4抑制模仿了PADI4KO的发现,改善了新陈代谢和减少了肝硬化.
结论:
- PADI4介导的NETosis作用于微生物群-肠道接口,导致超透性和细菌产品溢出.
- 这一过程对HFD的代谢后果有着显著的贡献.
- PADI4是一种可用药物的标,用于减轻不健康微生物群的代谢影响.
更多相关视频
相关概念视频
Chronic Pancreatitis I: Introduction
64
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
64
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
347
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
347
Gastritis-II: Pathophysiology
212
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
212
Chronic Bowel Disorders: Introduction
384
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
384
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.0K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.0K
Irritable Bowel Syndrome I: Introduction
231
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
231


